| Name | 4-oxo-3,5-dihydropyrrolo[2,3-c]quinoline-1-carboxylic acid |
|---|
| Molecular Formula | C12H8N2O3 |
|---|---|
| Molecular Weight | 228.20400 |
| Exact Mass | 228.05300 |
| PSA | 86.21000 |
| LogP | 2.11990 |
|
~97%
503272-05-7 |
| Literature: Pierre Fabre Medicament Patent: US2009/42876 A1, 2009 ; Location in patent: Page/Page column 20 ; |
|
~0%
503272-05-7 |
| Literature: Pierre Fabre Medicament Patent: US2009/42876 A1, 2009 ; Location in patent: Page/Page column 22 ; |
|
~%
503272-05-7 |
| Literature: Bergman, Jan; Rehn, Stanley Tetrahedron, 2002 , vol. 58, # 45 p. 9179 - 9185 |
|
~%
503272-05-7 |
| Literature: Bergman, Jan; Rehn, Stanley Tetrahedron, 2002 , vol. 58, # 45 p. 9179 - 9185 |
|
~%
503272-05-7 |
| Literature: Bergman, Jan; Rehn, Stanley Tetrahedron, 2002 , vol. 58, # 45 p. 9179 - 9185 |
| Precursor 4 | |
|---|---|
| DownStream 0 | |